Clinical Trial Update: Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring azithromycin as host-directed therapy for pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Tuberculosis, Pulmonary | Phase 2 | Status: COMPLETED